Sanofi, Long-Time Leader In Diabetes, Is Exiting Diabetes Research

 
• By Jessica Merrill
  
Lyon France, 3 October 2017: White logo of the french multinational pharmaceutical company Sanofi on their glass office building in Lyon France
Sanofi Plans To Discontinue Diabetes And Cardiovascular Disease Research.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category